Equities

Exlservice Holdings Inc

Exlservice Holdings Inc

Actions
  • Price (USD)122.94
  • Today's Change-1.56 / -1.25%
  • Shares traded154.94k
  • 1 Year change+63.40%
  • Beta0.8910
Data delayed at least 15 minutes, as of Oct 27 2021 21:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

ExlService Holdings, Inc. is an operations management and analytics company that operates in the business process management (BPM) industry. The Company's segments include Insurance, Healthcare, Analytics and Emerging Business. The Insurance segment serves property and casualty insurance, life insurance, annuity, and retirement services companies. It provides BPM services related to business processes in the insurance industry. The Healthcare segment serves the United States-based healthcare payers, pharmacy benefit managers and life sciences organizations. It provides BPM services related to Care Management, Utilization Management, and disease management. The Analytics segment offers services focused on driving improved business outcomes for its customers by unlocking insights from data and create data-driven solutions across all parts of its customers’ businesses. The Emerging Business segment provides data-driven and digital enterprise solutions in the areas of revenue management.

  • Revenue in USD (TTM)1.03bn
  • Net income in USD118.59m
  • Incorporated2002
  • Employees31.90k
  • Location
    Exlservice Holdings Inc320 Park Ave Fl 29NEW YORK 10022-6815United StatesUSA
  • Phone+1 (212) 277-7100
  • Fax+1 (212) 277-7111
  • Websitehttp://www.exlservice.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ziprecruiter Inc-100.00bn-100.00bn3.17bn772.00--21.19----------1.30----------------------------0.00---2.66--725.73------
Recursion Pharmaceuticals Inc-100.00bn-100.00bn3.18bn218.00--4.94----------3.82----------------------------0.0192--70.85---40.61------
Lyell Immunopharma Inc-100.00bn-100.00bn3.44bn188.00--3.41----------4.21----------------------------0.00--1,080.52---58.04------
Adagio Therapeutics Inc-100.00bn-100.00bn3.54bn68.00--------------3.24----------------------------0.00--------------
Frontdoor Inc1.55bn95.00m3.62bn2.19k38.171,208.0928.102.331.111.1118.120.0351.25--172.67709,589.107.61--11.47--47.6848.186.1110.44--4.080.99530.007.999.96-26.80-1.3735.52--
UniFirst Corp1.83bn151.11m3.75bn14.00k25.032.0014.602.057.947.9495.9299.170.79759.149.15--6.606.837.347.5837.5137.038.277.793.77----6.051.224.4611.303.976.3546.14
Aurinia Pharmaceuticals Inc57.59m-147.59m3.83bn294.00--11.56--66.58-1.16-1.160.4642.590.1695--23.28195,894.60-43.43-36.17-46.66-38.2512.46---256.27-678.3011.34--0.00--15,660.38192.27-16.17--171.26--
Sana Biotechnology Inc-100.00bn-100.00bn3.85bn321.00--4.09----------5.02----------------------------0.00-------118.16------
Korn Ferry2.06bn215.01m4.05bn7.89k18.402.8614.191.964.044.0438.7826.000.7414--4.64261,270.308.014.739.956.1995.6593.6010.816.11----0.218521.09-7.966.217.6029.533.550.00
ExlService Holdings, Inc.1.03bn118.59m4.12bn31.90k35.665.6124.344.013.453.4529.8421.900.8688280.515.9732,177.1210.057.5012.049.0738.3934.4311.578.282.60--0.17540.00-3.328.8132.2511.6510.54--
AbCellera Biologics Inc-100.00bn-100.00bn4.28bn206.00--4.40----------3.49------------------------12.37--0.0018--1,907.96--5,479.20------
AMN Healthcare Services, Inc.2.93bn172.52m4.55bn3.00k26.744.7116.661.563.603.6061.1520.451.17--5.72975,430.706.907.368.569.3032.8632.855.905.17--6.200.46550.007.7210.35-38.01-2.917.68--
Insperity Inc4.54bn111.08m4.75bn3.60k42.9753.9432.861.052.862.86117.422.282.80--8.481,260,100.006.8610.0615.8827.8117.7117.602.463.09--33.230.808940.38-0.644310.49-7.9629.0540.6330.36
FTI Consulting, Inc.2.65bn233.04m4.88bn6.41k21.803.2817.551.846.536.5374.0343.440.938--3.39418,698.508.265.9810.217.4431.3633.448.816.94--11.820.20820.004.616.71-2.3026.112.12--
Driven Brands Holdings Inc1.26bn11.86m4.91bn6.90k473.362.9345.563.890.06190.06197.7510.01------182,683.80--------44.37--0.9422--0.97852.280.4765--50.63---154.31------
Terminix Global Holdings Inc2.00bn59.00m4.97bn11.40k86.601.9929.962.480.46074.2515.2520.020.404226.809.69175,614.001.110.80471.270.947541.7644.592.752.031.253.950.25930.00-5.58-5.44-84.50-34.19-8.25--
Data as of Oct 27 2021. Currency figures normalised to Exlservice Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

55.20%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 20214.63m13.97%
The Vanguard Group, Inc.as of 30 Jun 20213.44m10.38%
Wellington Management Co. LLPas of 30 Jun 20212.01m6.06%
Fidelity Management & Research Co. LLCas of 30 Jun 20211.91m5.76%
Mackenzie Financial Corp.as of 30 Jun 20211.49m4.49%
Macquarie Investment Management Business Trustas of 30 Jun 20211.07m3.21%
SSgA Funds Management, Inc.as of 30 Jun 20211.06m3.21%
Dimensional Fund Advisors LPas of 30 Jun 2021996.65k3.00%
Fidelity Investments Canada ULCas of 31 Aug 2021870.79k2.63%
FIL Investment Advisors (UK) Ltd.as of 30 Jun 2021823.24k2.48%
More ▼
Data from 30 Jun 2021 - 31 Aug 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.